Found: 32
Select item for more details and to access through your institution.
Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 4, p. 1030, doi. 10.1210/clinem/dgab851
- By:
- Publication type:
- Article
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 11, p. 4935, doi. 10.1172/JCI69766
- By:
- Publication type:
- Article
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Switch in signaling control of mTORC1 activity after oncoprotein expression in thyroid cancer cell lines.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.
- Published in:
- 2008
- By:
- Publication type:
- journal article
BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines.
- Published in:
- 2008
- By:
- Publication type:
- journal article
BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 11, p. 5399, doi. 10.1210/jc.2003-030838
- By:
- Publication type:
- Article
Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01676-9
- By:
- Publication type:
- Article
Acute expression of RET/PTC induces isozyme-specific activation and subsequent downregulation of PKC? in PCCL3 thyroid cells.
- Published in:
- Oncogene, 2003, v. 22, n. 44, p. 6830, doi. 10.1038/sj.onc.1206829
- By:
- Publication type:
- Article
RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase.
- Published in:
- Oncogene, 2003, v. 22, n. 28, p. 4406, doi. 10.1038/sj.onc.1206602
- By:
- Publication type:
- Article
91st American Thyroid Association Annual Meeting Preview: Live and in Person in Montréal! October 19–23, 2022 Montréal, Quebec, Canada.
- Published in:
- 2022
- By:
- Publication type:
- Proceeding
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
- Published in:
- Thyroid, 2022, v. 32, n. 3, p. 273, doi. 10.1089/thy.2021.0565
- By:
- Publication type:
- Article
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.
- Published in:
- Thyroid, 2019, v. 29, n. 1, p. 79, doi. 10.1089/thy.2018.0424
- By:
- Publication type:
- Article
BRAF V600E Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4687, doi. 10.3390/cancers14194687
- By:
- Publication type:
- Article
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway.
- Published in:
- Oncogene, 2000, v. 19, n. 34, p. 3948, doi. 10.1038/sj.onc.1203723
- By:
- Publication type:
- Article
Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.
- Published in:
- Nucleic Acids Research, 1997, v. 25, n. 19, p. 3823, doi. 10.1093/nar/25.19.3823
- By:
- Publication type:
- Article
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer: A Single-Institution 21-Year Experience.
- Published in:
- JAMA Otolaryngology-Head & Neck Surgery, 2023, v. 149, n. 4, p. 300, doi. 10.1001/jamaoto.2022.5045
- By:
- Publication type:
- Article
Mouse Models as a Tool for Understanding Progression in Braf<sup>V600E</sup>-Driven Thyroid Cancers.
- Published in:
- Endocrinology & Metabolism, 2019, v. 34, n. 1, p. 11, doi. 10.3803/EnM.2019.34.1.11
- By:
- Publication type:
- Article
Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.
- Published in:
- Endocrine (1355008X), 2019, v. 64, n. 1, p. 97, doi. 10.1007/s12020-019-01848-6
- By:
- Publication type:
- Article
BRAF V600E Induction in Thyrocytes Triggers Important Changes in the miRNAs Content and the Populations of Extracellular Vesicles Released in Thyroid Tumor Microenvironment.
- Published in:
- Biomedicines, 2022, v. 10, n. 4, p. 755, doi. 10.3390/biomedicines10040755
- By:
- Publication type:
- Article
Does the Epidermal Growth Factor Receptor Play a Role in the Progression of Thyroid Cancer?
- Published in:
- Thyroid, 2011, v. 21, n. 11, p. 1171, doi. 10.1089/thy.2011.2111.ed
- By:
- Publication type:
- Article
Molecular, Morphologic, and Outcome Analysis of Thyroid Carcinomas According to Degree of Extrathyroid Extension.
- Published in:
- Thyroid, 2010, v. 20, n. 10, p. 1085, doi. 10.1089/thy.2010.0174
- By:
- Publication type:
- Article
Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 10, p. 4889, doi. 10.1210/jc.2019-00431
- By:
- Publication type:
- Article
Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 5, p. 1417, doi. 10.1210/jc.2018-01478
- By:
- Publication type:
- Article
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1.
- Published in:
- Clinical Endocrinology, 2002, v. 56, n. 3, p. 341, doi. 10.1046/j.1365-2265.2002.01475.x
- By:
- Publication type:
- Article